Citation Impact
Citing Papers
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera
2004
Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia
1998
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
On the allelic spectrum of human disease
2001
Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.
1989 StandoutNobel
The role of FLT3 in haematopoietic malignancies
2003
The Association of Atopy with a Gain-of-Function Mutation in the α Subunit of the Interleukin-4 Receptor
1997
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia.
1994 StandoutNobel
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts
1997
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
1993 StandoutNature
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants
2000
Hereditary stomatocytosis and cation leaky red cells — Recent developments
2009
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
1996
Mersalyl Is a Novel Inducer of Vascular Endothelial Growth Factor Gene Expression and Hypoxia-Inducible Factor 1 Activity
1998 StandoutNobel
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
2002
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
1998
Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients
2010
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels
2013 StandoutNobel
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Biology of Natural Killer Cells
1989 Standout
Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
2001
Differential control of band 3 lateral and rotational mobility in intact red cells.
1994 StandoutNobel
Amplification of a gene encoding a p53-associated protein in human sarcomas
1992 StandoutNature
Mice lacking MHC class II molecules
1991
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
2006 StandoutNobel
Expression and purification of recombinant cytoplasmic domain of human erythrocyte band 3 with hexahistidine tag or chitin-binding tag in Escherichia coli
2004
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
1995 Nature
G6PD Ferrara I has the same two mutations as G6PD A(-) but a distinct biochemical phenotype
1994
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Glucose 6‐phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia
1994
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Congenital cytomegalovirus: Immunological alterations
1987
Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor
2010 StandoutNobel
Polycythemia vera and other primary polycythemias
2005
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo
2007
The Primary Immunodeficiencies
1995
Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
1998
GenetiC Mechanisms Underlying Regulation of Hemoglobin Mass
2007
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Molecular basis for polycythemia
1999
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The Immune System of Mice Lacking Conventional MHC Class II Molecules
1993
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Epstein–Barr Virus Infection
2000 Standout
Cancer of the Ovary
2004 Standout
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
2008 StandoutNobel
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East.
1990
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
2000
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
2000
Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium [see comments]
1994
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Molecular Analysis of Eight Biochemically Unique Glucose-6-Phosphate Dehydrogenase Variants Found in Japan
1997
Hereditary elliptocytosis, spherocytosis and related disorders: Consequences of a deficiency or a mutation of membrane skeletal proteins
1987
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
1998 StandoutNobel
Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A-.
1991
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.
1996 StandoutNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
1982
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
1998 StandoutScience
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway
1996
Mutations in the VHL gene in sporadic apparently congenital polycythemia
2003
Human Hematopoietic Progenitors Express Erythropoietin
1998
Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants.
1989
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
1997
Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin
2003
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Hypoxia. 5. Hypoxia and hematopoiesis
2011
Congenital and inherited polycythemia
2000
Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.
1986
Red cell membrane: past, present, and future
2008
Isolation and characterization of Leu 7+ germinal-center cells with the T helper-cell phenotype and granular lymphocyte morphology
1986
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
New mutations and pathogenesis of myeloproliferative neoplasms
2011
Quantitative and functional analysis of a human lymphocyte subset with the T-helper (Leu 3/T 4+) phenotype and natural killer (NK)-cell characteristics in patients with malignancy
1985
Glucose-6-Phosphate Dehydrogenase
1985
Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme
1996
Ongoing In Vivo Immunoglobulin Class Switch DNA Recombination in Chronic Lymphocytic Leukemia B Cells
2002
Carrier Detection in X-Linked Agammaglobulinemia by Analysis of X-Chromosome Inactivation
1987
Clonal analysis using recombinant DNA probes from the X-chromosome.
1987
Congenital Polycythemia in Chuvashia
1997
A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
1999
Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets
1997
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes
1999
Hematologically Important Mutations: Glucose-6-Phosphate Dehydrogenase
1997
Annotation
1996
Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion
1997 StandoutNobel
Multiple G6PD mutations are associated with a clinical and biochemical phenotype similar to that of G6PD Mediterranean
1996
Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy.
1997
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Polycythemia in transgenic mice expressing the human erythropoietin gene.
1989 StandoutNobel
The Primary Immunodeficiencies
1984
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
2000
Bone Marrow Failure Syndromes
1999
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease
2003
New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia
1995
G6PD deficiency as protection againstfalciparum malaria: An epidemiologic critique of population and experimental studies
1993
Defective Lymphoid Development in Mice Lacking Jak3
1995 StandoutScienceNobel
Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.
1993 StandoutNobel
Works of JT Prchal being referenced
Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis [letter]
1993
Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia.
1994
The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia.
1997
Erythropoietin receptor mutations and human disease.
1997
Clonality in juvenile chronic myelogenous leukemia
1995
Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis [letter]
1993
Molecular determinants of clinical expression of hereditary elliptocytosis and pyropoikilocytosis
1987
Evolving understanding of the cellular defect in polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology [editorial; comment]
1994
Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera
1994
A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndrome
1980
Expression of NK-lineage markers on peripheral blood lymphocytes with T- helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia
1985
Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin
1995
Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-
1989
Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-
1989
Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome)
1987
Band 3 Tuscaloosa: Pro327----Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2
1992
Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency
1996
Autosomal dominant polycythemia
1985
Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection
1980
Band 3 Tuscaloosa: Pro327----Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2
1992
A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndrome
1980
Structural and functional heterogeneity of alpha spectrin mutations involving the spectrin heterodimer self-association site: relationships to hematologic expression of homozygous hereditary elliptocytosis and hereditary pyropoikilocytosis
1990
Molecular basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis: evidence implicating a primary defect of ankyrin
1991
Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome)
1987
New glucose-6-phosphate dehydrogenase mutations from various ethnic groups
1992
Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia
1995
Autosomal dominant polycythemia
1985
New glucose-6-phosphate dehydrogenase mutations from various ethnic groups
1992
Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients.
1996
Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection
1980